Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Characteristics and Therapeutic Response of Erdheim-Chester Disease Associated with Myeloid Neoplasm, an Observational Multicenter Study

Ambroise Le Pogam, Matthias Papo, Pierre Hirsh, Jean-Francois Emile, Pierre Duffau, Jerome Razanamahery, Estibaliz Lazarro, Damiens Roos-Weil, Fleur Cohen-Aubart, Vincent Jachiet, Arsene Mekinian, Olivier Fain, Zahir Amoura, Jerome Hadjadj, Julien Haroche

Blood (2024) 144 (Supplement 1): 4553.

https://doi.org/10.1182/blood-2024-209641

Published: 2024

Journal Articles

Epidemiology and geographic clustering of Erdheim-Chester disease in Italy and France

Blood (2023) 142 (24): 2119–2123.

https://doi.org/10.1182/blood.2023021670

Published: 2023

Includes: Supplemental data

Journal Articles

High Prevalence of Vulvar and Hepatic Manifestations in a Series of 18 Histiocytosis with Brafdel Mutations

Matthias Papo, Julien Haroche, Malik Da Silva, Zofia Helias-Rodzewicz, Vsevolod Potapenko, Suzanna Bota, Leguy-Seguin Vanessa, Stéphane Dominique, Marion Campana, Visal Keo, Zahir Amoura, Jean-Francois Emile

Blood (2023) 142 (Supplement 1): 6392.

https://doi.org/10.1182/blood-2023-174667

Published: 2023

Journal Articles

Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patients

Blood (2023) 142 (13): 1167–1171.

https://doi.org/10.1182/blood.2023020569

Published: 2023

Includes: Supplemental data

Journal Articles

NT-Probnp and High-Sensitivity Troponin T Fail to Detect Cardiac Involvement in Erdheim-Chester Disease

Levi-Dan Azoulay, Chezi Ganzel, Marine Bravetti, Zahir Amoura, Jean Donadieu, Philippe Cluzel, Fleur Cohen-Aubart, Julien Haroche

Blood (2022) 140 (Supplement 1): 3997–3998.

https://doi.org/10.1182/blood-2022-157532

Published: 2022

Journal Articles

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults

Gaurav Goyal, Abdellatif Tazi, Ronald S. Go, Karen L. Rech, Jennifer L. Picarsic, Robert Vassallo, Jason R. Young, Christian W. Cox, Jan Van Laar, Michelle L. Hermiston, Xin-Xin Cao, Polyzois Makras, Gregory Kaltsas, Julien Haroche, Matthew Collin, Kenneth L. McClain, Eli L. Diamond, Michael Girschikofsky

Blood (2022) 139 (17): 2601–2621.

https://doi.org/10.1182/blood.2021014343

Published: 2022

Includes: Supplemental data

Journal Articles

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Paul G. Kemps, Jennifer Picarsic, Benjamin H. Durham, Zofia Hélias-Rodzewicz, Laura Hiemcke-Jiwa, Cor van den Bos, Marianne D. van de Wetering, Carel J. M. van Noesel, Jan A. M. van Laar, Robert M. Verdijk, Uta E. Flucke, Pancras C. W. Hogendoorn, F. J. Sherida H. Woei-A-Jin, Raf Sciot, Andreas Beilken, Friedrich Feuerhake, Martin Ebinger, Robert Möhle, Falko Fend, Antje Bornemann, Verena Wiegering, Karen Ernestus, Tina Méry, Olga Gryniewicz-Kwiatkowska, Bozenna Dembowska-Baginska, Dmitry A. Evseev, Vsevolod Potapenko, Vadim V. Baykov, Stefania Gaspari, Sabrina Rossi, Marco Gessi, Gianpiero Tamburrini, Sébastien Héritier, Jean Donadieu, Jacinthe Bonneau-Lagacherie, Claire Lamaison, Laure Farnault, Sylvie Fraitag, Marie-Laure Jullié, Julien Haroche, Matthew Collin, Jackie Allotey, Majid Madni, Kerry Turner, Susan Picton, Pasquale M. Barbaro, Alysa Poulin, Ingrid S. Tam, Dina El Demellawy, Brianna Empringham, James A. Whitlock, Aditya Raghunathan, Amy A. Swanson, Mariko Suchi, Jon M. Brandt, Nabeel R. Yaseen, Joanna L. Weinstein, Irem Eldem, Bryan A. Sisk, Vaishnavi Sridhar, Mandy Atkinson, Lucas R. Massoth, Jason L. Hornick, Sanda Alexandrescu, Kee Kiat Yeo, Kseniya Petrova-Drus, Stephen Z. Peeke, Laura S. Muñoz-Arcos, Daniel G. Leino, David D. Grier, Robert Lorsbach, Somak Roy, Ashish R. Kumar, Shipra Garg, Nishant Tiwari, Kristian T. Schafernak, Michael M. Henry, Astrid G. S. van Halteren, Oussama Abla, Eli L. Diamond, Jean-François Emile

Blood (2022) 139 (2): 256–280.

https://doi.org/10.1182/blood.2021013338

Published: 2022

Includes: Supplemental data

Journal Articles

Pediatric Erdheim-Chester Disease in the Molecular Era: A Multicenter Case Series

Francesco Pegoraro, Elena Gelain, Stefania Gaspari, Jean Donadieu, Jean-François Emile, Elena Sieni, Julien Haroche, Augusto Vaglio

Blood (2021) 138 (Supplement 1): 4194.

https://doi.org/10.1182/blood-2021-150140

Published: 2021

Journal Articles

Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease

Blood (2021) 138 (17): 1554–1569.

https://doi.org/10.1182/blood.2020009594

Published: 2021

Includes: Supplemental data

Journal Articles

High frequency of clonal hematopoiesis in Erdheim-Chester disease

Fleur Cohen Aubart, Damien Roos-Weil, Marine Armand, Alice Marceau-Renaut, Jean-François Emile, Nicolas Duployez, Frédéric Charlotte, Stéphanie Poulain, Raphael Lhote, Zofia Hélias-Rodzewicz, Véronique Della-Valle, Olivier Bernard, Karim Maloum, Florence Nguyen-Khac, Jean Donadieu, Zahir Amoura, Omar Abdel-Wahab, Julien Haroche

Blood (2021) 137 (4): 485–492.

https://doi.org/10.1182/blood.2020005101

Published: 2021

Includes: Supplemental data

Journal Articles

Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era

Blood (2020) 135 (22): 1929–1945.

https://doi.org/10.1182/blood.2019003507

Published: 2020

Journal Articles

Erdheim-Chester disease

Julien Haroche, Fleur Cohen-Aubart, Zahir Amoura

Blood (2020) 135 (16): 1311–1318.

https://doi.org/10.1182/blood.2019002766

Published: 2020

Journal Articles

High Serum VEGF Level in Erdheim-Chester Disease: Correlation with Cardiovascular Involvement and Response to Treatment

Anaïs Roeser, MD, Marine Bravetti, MD, Levi-Dan Azoulay, MD, Makoto Miyara, MD, Jean-François Emile, MD, Jean Donadieu, MD PhD, Zahir Amoura, MD MSc, Fleur Cohen-Aubart, MD PhD, Julien Haroche

Blood (2019) 134 (Supplement_1): 2324.

https://doi.org/10.1182/blood-2019-129984

Published: 2019

Journal Articles

Classification and Prognosis of Central Nervous System Involvement in Erdheim-Chester Disease

Fleur Cohen-Aubart, MD PhD, Ahmed Idbaih, MD PhD, Damien Galanaud, MD PhD, Bruno Law-Ye, MD, Jean-François Emile, MD PhD, Frédéric Charlotte, MD, Jean Donadieu, MD PhD, Zahir Amoura, MD MSc, Julien Haroche

Blood (2019) 134 (Supplement_1): 4272.

https://doi.org/10.1182/blood-2019-130606

Published: 2019

Journal Articles

PD-1/ PD-L1 Expression Is Associated with Tissue Inflammation and BRAF Status in Erdheim-Chester Disease

Frédéric Charlotte, MD, Fleur Cohen-Aubart, MD PhD, Levi-Dan Azoulay, MD, Jean Donadieu, MD PhD, Jean-François Emile, MD PhD, Zahir Amoura, MD, Julien Haroche

Blood (2018) 132 (Supplement 1): 4380.

https://doi.org/10.1182/blood-2018-99-114031

Published: 2018

Journal Articles

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

Oussama Abla, Eric Jacobsen, Jennifer Picarsic, Zdenka Krenova, Ronald Jaffe, Jean-Francois Emile, Benjamin H. Durham, Jorge Braier, Frédéric Charlotte, Jean Donadieu, Fleur Cohen-Aubart, Carlos Rodriguez-Galindo, Carl Allen, James A. Whitlock, Sheila Weitzman, Kenneth L. McClain, Julien Haroche, Eli L. Diamond

Blood (2018) 131 (26): 2877–2890.

https://doi.org/10.1182/blood-2018-03-839753

Published: 2018

Journal Articles

Clonal Hematopoiesis in Erdheim-Chester Disease

Julien Haroche, MD PhD, Stéphanie Poulain, MD PhD, Alice Marceau-Renaut, PharmD, Aline Renneville, Catherine Settegrana, Karim Maloum, Damien Roos-Weil, Florence Nguyen-Khac, MD PhD, Jean Donadieu, MD, Jean-François Emile, MD PhD, Zahir Amoura, Fleur Cohen-Aubart, MD PhD

Blood (2017) 130 (Supplement 1): 3788.

https://doi.org/10.1182/blood.V130.Suppl_1.3788.3788

Published: 2017

Journal Articles

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)

Fleur Cohen Aubart, Jean-François Emile, Fabrice Carrat, Frédéric Charlotte, Neila Benameur, Jean Donadieu, Philippe Maksud, Ahmed Idbaih, Stéphane Barete, Khê Hoang-Xuan, Zahir Amoura, Julien Haroche

Blood (2017) 130 (11): 1377–1380.

https://doi.org/10.1182/blood-2017-03-771873

Published: 2017

Includes: Supplemental data

Journal Articles

High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis

Blood (2017) 130 (8): 1007–1013.

https://doi.org/10.1182/blood-2017-01-761718

Published: 2017

Includes: Supplemental data

Journal Articles

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells

Blood (2017) 130 (2): 176–180.

https://doi.org/10.1182/blood-2016-12-757377

Published: 2017

Includes: Supplemental data

NARROW

Characteristics and Therapeutic Response of Erdheim-Chester Disease Associated with Myeloid Neoplasm, an Observational Multicenter Study

Epidemiology and geographic clustering of Erdheim-Chester disease in Italy and France

High Prevalence of Vulvar and Hepatic Manifestations in a Series of 18 Histiocytosis with Brafdel Mutations

Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patients

NT-Probnp and High-Sensitivity Troponin T Fail to Detect Cardiac Involvement in Erdheim-Chester Disease

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Pediatric Erdheim-Chester Disease in the Molecular Era: A Multicenter Case Series

Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease

High frequency of clonal hematopoiesis in Erdheim-Chester disease

Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era

Erdheim-Chester disease

High Serum VEGF Level in Erdheim-Chester Disease: Correlation with Cardiovascular Involvement and Response to Treatment

Classification and Prognosis of Central Nervous System Involvement in Erdheim-Chester Disease

PD-1/ PD-L1 Expression Is Associated with Tissue Inflammation and BRAF Status in Erdheim-Chester Disease

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

Clonal Hematopoiesis in Erdheim-Chester Disease

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)

High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only